Morgan Stanley
OSTX

Morgan Stanley’s OS Therapies Inc OSTX Stock Holding History

Morgan Stanley’s Portfolio OSTX Stock Details OSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.7K Buy
13,000
+3,510
+37% +$5.89K ﹤0.01% 6739
2026
Q1 		$13.4K Buy
9,490
+8,490
+849% +$12.1K ﹤0.01% 6860
2025
Q4 		$1.4K Hold
1,000
– – ﹤0.01% 7309
2025
Q3 		$1.96K Buy
1,000
+260
+35% +$515 ﹤0.01% 7310
2025
Q2 		$1.39K Buy
740
+737
+24,567% +$1.24K ﹤0.01% 7294
2025
Q1 		$5 Sell
3
-1,878
-100% -$4.41K ﹤0.01% 8033
2024
Q4 		$8.05K Buy
+1,881
New +$5.51K ﹤0.01% 6876

Other funds holding OSTX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HFS
Howard Financial Services Dallas, Texas $1B AUM 20.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley's OSTX Position: Q2 2026 in Review

Morgan Stanley increased its OS Therapies Inc (OSTX) stake by 37% in Q2 2026, buying an estimated $5.89K and bringing the position to 13,000 shares worth $24.7K. The position accounts for ﹤0.01% of the portfolio, ranked #6739.

Morgan Stanley first reported a position in OSTX in Q4 2024 and has held it in 7 quarters since. 29 funds tracked by Wall St. Rank hold OSTX as of Q2 2026.

  • Morgan Stanley held 13,000 shares of OS Therapies Inc worth $24.7K as of Q2 2026.
  • Morgan Stanley bought 3,510 OS Therapies Inc shares in Q2 2026, an estimated $5.89K.
  • OS Therapies Inc made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6739 holding.
  • Morgan Stanley first reported a position in OS Therapies Inc in Q4 2024 and has held it in 7 quarters since.
  • 29 funds tracked by Wall St. Rank held OS Therapies Inc as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.